Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-03 2020-05-08 110797
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-05-29 111823
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-06-04 111826
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-23 2020-05-08 113043
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-08 113726
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-21 113761
TEVA-MORPHINE SR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-18 2020-10-22 118247
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-25 2021-04-29 118960
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-09 2020-08-27 119889
ACT CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-09 2023-04-28 119901
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2021-09-30 120473
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2020-09-17 120485
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-08-20 2020-09-03 122720
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-01 2020-10-30 125467
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-30 2021-04-01 127616
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-06 2021-01-28 128025
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-12-17 2021-01-21 130291
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2021-01-28 2021-02-05 132639
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-04-29 133770
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-05-27 133776

Showing 61 to 80 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330

Showing 221 to 240 of 250